Clovis Oncology Obtains $130,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dd20c204-b49a-4983-aace-1915326081aa&Preview=1 - Date
11/15/2011 - Company Name
Clovis Oncology - Mailing Address
2525 28th Street Boulder, CO 80301 - Company Description
Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. - Website
http://www.Clovisoncology.com - Transaction Type
IPO - Transaction Amount
$130,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC. - M&A Terms
